drugset

drugset / Trial / NCT06108349

Topical Cannabidiol for Treating Carpal Tunnel Syndrome

NCT06108349 ↗

Phase 2 Not yet recruiting 20 enrolled University of Virginia

RandomizedCrossoverDouble-blindTreatment

Summary

The Purpose of this study is to assess the safety and efficacy of Cannabidiol on treatment of Carpal Tunnel Syndrome.

Timeline

Start: 2025-07-01
Primary completion: 2026-12-01
Completion: 2027-01-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cannabidiol	Other / unclassified	—	Topical

Indications